Fieldpoint Private Securities’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-70
Closed -$3K 1748
2022
Q1
$3K Buy
+70
New +$3.61K ﹤0.01% 1444

Other funds holding ASTH

Fieldpoint Private Securities's ASTH Position: Q2 2022 in Review

Fieldpoint Private Securities sold out of Astrana Health (ASTH) in Q2 2022, closing a stake of 70 shares — an estimated $3K sold.

Fieldpoint Private Securities first reported a position in ASTH in Q1 2022 and held it in 1 quarter. The position peaked at $3K in Q1 2022. 134 funds tracked by Wall St. Rank hold ASTH as of Q2 2022.

  • Fieldpoint Private Securities reported no remaining Astrana Health position as of Q2 2022 after selling out during the quarter.
  • Fieldpoint Private Securities sold 70 Astrana Health shares in Q2 2022, an estimated $3K.
  • Fieldpoint Private Securities first reported a position in Astrana Health in Q1 2022 and held it in 1 quarter.
  • Fieldpoint Private Securities's Astrana Health position peaked at $3K in Q1 2022.
  • 134 funds tracked by Wall St. Rank held Astrana Health as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.